(Q33748109)

29 July 2017

1 reference

title

Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines (English)

1 reference

29 July 2017

Dalakas MC

1

1 reference

29 July 2017

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

22

1 reference

29 July 2017

1479-1497

1 reference

29 July 2017

11

1 reference

Clinical uses of intravenous immunoglobulins

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Complications of intravenous immune globulin treatment in neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Intravenous immune globulin therapy for neurologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Patterns of recovery in the Guillain-Barre syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Successful treatment of neuropathies in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28199911%2922%3A11%3C1479%3A%3AAID-MUS3%3E3.0.CO%3B2-B

10.1002/(SICI)1097-4598(199911)22:11<1479::AID-MUS3>3.0.CO;2-B

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10514226